David Fairlie
David is Head of Chemistry and Structural Biology at the Institute for Molecular Bioscience, University of Queensland. He was educated at University of Adelaide, Australian National University, University of New South Wales, Stanford University and University of Toronto. He has continuously held ARC and NHMRC Fellowships since 2002 and consulted to and collaborated with numerous pharma companies worldwide. His research at chemistry-biology interfaces has focussed on design of small organic molecules that modulate enzymes, GPCRs, protein-protein interactions, cell signalling pathways, and on elucidating mechanisms of disease development, immune responses and drug action.
Abstracts this author is presenting:
